Global Tuberculosis Vaccine Treatment Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Tuberculosis Vaccine Treatment market size is predicted to grow from US$ 76.6 million in 2025 to US$ 91.5 million in 2031; it is expected to grow at a CAGR of 3.0% from 2025 to 2031.
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
LP Information, Inc. (LPI) ' newest research report, the “Tuberculosis Vaccine Treatment Industry Forecast” looks at past sales and reviews total world Tuberculosis Vaccine Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Tuberculosis Vaccine Treatment sales for 2025 through 2031. With Tuberculosis Vaccine Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Vaccine Treatment industry.
This Insight Report provides a comprehensive analysis of the global Tuberculosis Vaccine Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Vaccine Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis Vaccine Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Vaccine Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Vaccine Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Vaccine Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Tuberculosis Vaccine Treatment market?
What factors are driving Tuberculosis Vaccine Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tuberculosis Vaccine Treatment market opportunities vary by end market size?
How does Tuberculosis Vaccine Treatment break out by Type, by Application?
The global Tuberculosis Vaccine Treatment market size is predicted to grow from US$ 76.6 million in 2025 to US$ 91.5 million in 2031; it is expected to grow at a CAGR of 3.0% from 2025 to 2031.
Tuberculosis Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guйrin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80% of neonates and infants in countries where it is part of the national childhood immunization programme.
Besides, BCG Vaccine is also used to treat a certain type of bladder cancer. Bladder cancer is the growth of abnormal or cancerous cells on the inner lining of the bladder wall. BCG helps prevent the cancer from coming back in the bladder lining, and also reduces the risk of it becoming invasive.
In the last several years, global market of Tuberculosis Vaccine Treatment developed smoothly, with an average growth rate of 0.73%.
The classification of Tuberculosis Vaccine Treatment includes Immune Vaccine and Therapy Vaccine, and the proportion of Immune Vaccine in 2019 is about 99.66%.
Tuberculosis Vaccine Treatment is widely sold through Self-Procurement, UNICEF and Other. The most proportion of Tuberculosis Vaccine Treatment is sold through Self-Procurement, and the proportion in 2019 is 62.14%.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 45% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of 35.66%.
Market competition is intense. Merck, Japan BCG Lab, Serum Institute of India are the leaders of the industry, they occupy the 60% of the market.
LP Information, Inc. (LPI) ' newest research report, the “Tuberculosis Vaccine Treatment Industry Forecast” looks at past sales and reviews total world Tuberculosis Vaccine Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Tuberculosis Vaccine Treatment sales for 2025 through 2031. With Tuberculosis Vaccine Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Vaccine Treatment industry.
This Insight Report provides a comprehensive analysis of the global Tuberculosis Vaccine Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Vaccine Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tuberculosis Vaccine Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Vaccine Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Vaccine Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Vaccine Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Immune Vaccine
- Therapy Vaccine
- Self-Procurement
- UNICEF
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Japan BCG Lab
- Serum Institute of India
- AJ Vaccines
- BioFarma
- GreenSignal Bio Pharma
- China National Biotec
- Biomed Lublin
- Taj Pharmaceuticals
- Ataulpho de Paiva
- IVAC
- Queen Saovabha Mem. Inst
- Microgen
What is the 10-year outlook for the global Tuberculosis Vaccine Treatment market?
What factors are driving Tuberculosis Vaccine Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tuberculosis Vaccine Treatment market opportunities vary by end market size?
How does Tuberculosis Vaccine Treatment break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tuberculosis Vaccine Treatment Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Tuberculosis Vaccine Treatment by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Tuberculosis Vaccine Treatment by Country/Region, 2020, 2024 & 2031
2.2 Tuberculosis Vaccine Treatment Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 Tuberculosis Vaccine Treatment Sales by Type
2.3.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)
2.3.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Type (2020-2025)
2.3.3 Global Tuberculosis Vaccine Treatment Sale Price by Type (2020-2025)
2.4 Tuberculosis Vaccine Treatment Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Other
2.5 Tuberculosis Vaccine Treatment Sales by Application
2.5.1 Global Tuberculosis Vaccine Treatment Sale Market Share by Application (2020-2025)
2.5.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Application (2020-2025)
2.5.3 Global Tuberculosis Vaccine Treatment Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Tuberculosis Vaccine Treatment Breakdown Data by Company
3.1.1 Global Tuberculosis Vaccine Treatment Annual Sales by Company (2020-2025)
3.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Company (2020-2025)
3.2 Global Tuberculosis Vaccine Treatment Annual Revenue by Company (2020-2025)
3.2.1 Global Tuberculosis Vaccine Treatment Revenue by Company (2020-2025)
3.2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Company (2020-2025)
3.3 Global Tuberculosis Vaccine Treatment Sale Price by Company
3.4 Key Manufacturers Tuberculosis Vaccine Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tuberculosis Vaccine Treatment Product Location Distribution
3.4.2 Players Tuberculosis Vaccine Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TUBERCULOSIS VACCINE TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Tuberculosis Vaccine Treatment Market Size by Geographic Region (2020-2025)
4.1.1 Global Tuberculosis Vaccine Treatment Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Tuberculosis Vaccine Treatment Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tuberculosis Vaccine Treatment Market Size by Country/Region (2020-2025)
4.2.1 Global Tuberculosis Vaccine Treatment Annual Sales by Country/Region (2020-2025)
4.2.2 Global Tuberculosis Vaccine Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tuberculosis Vaccine Treatment Sales Growth
4.4 APAC Tuberculosis Vaccine Treatment Sales Growth
4.5 Europe Tuberculosis Vaccine Treatment Sales Growth
4.6 Middle East & Africa Tuberculosis Vaccine Treatment Sales Growth
5 AMERICAS
5.1 Americas Tuberculosis Vaccine Treatment Sales by Country
5.1.1 Americas Tuberculosis Vaccine Treatment Sales by Country (2020-2025)
5.1.2 Americas Tuberculosis Vaccine Treatment Revenue by Country (2020-2025)
5.2 Americas Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
5.3 Americas Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis Vaccine Treatment Sales by Region
6.1.1 APAC Tuberculosis Vaccine Treatment Sales by Region (2020-2025)
6.1.2 APAC Tuberculosis Vaccine Treatment Revenue by Region (2020-2025)
6.2 APAC Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
6.3 APAC Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tuberculosis Vaccine Treatment by Country
7.1.1 Europe Tuberculosis Vaccine Treatment Sales by Country (2020-2025)
7.1.2 Europe Tuberculosis Vaccine Treatment Revenue by Country (2020-2025)
7.2 Europe Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
7.3 Europe Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tuberculosis Vaccine Treatment by Country
8.1.1 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Country (2020-2025)
8.1.2 Middle East & Africa Tuberculosis Vaccine Treatment Revenue by Country (2020-2025)
8.2 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
8.3 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccine Treatment
10.3 Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
10.4 Industry Chain Structure of Tuberculosis Vaccine Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tuberculosis Vaccine Treatment Distributors
11.3 Tuberculosis Vaccine Treatment Customer
12 WORLD FORECAST REVIEW FOR TUBERCULOSIS VACCINE TREATMENT BY GEOGRAPHIC REGION
12.1 Global Tuberculosis Vaccine Treatment Market Size Forecast by Region
12.1.1 Global Tuberculosis Vaccine Treatment Forecast by Region (2026-2031)
12.1.2 Global Tuberculosis Vaccine Treatment Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Tuberculosis Vaccine Treatment Forecast by Type (2026-2031)
12.7 Global Tuberculosis Vaccine Treatment Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC
13.11.1 IVAC Company Information
13.11.2 IVAC Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 IVAC Main Business Overview
13.11.5 IVAC Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Tuberculosis VaccineTreatment Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Tuberculosis VaccineTreatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immune Vaccine
Table 4. Major Players ofTherapy Vaccine
Table 5. GlobalTuberculosis VaccineTreatment Sales byType (2020-2025) & (K Dose)
Table 6. GlobalTuberculosis VaccineTreatment Sales Market Share byType (2020-2025)
Table 7. GlobalTuberculosis VaccineTreatment Revenue byType (2020-2025) & ($ million)
Table 8. GlobalTuberculosis VaccineTreatment Revenue Market Share byType (2020-2025)
Table 9. GlobalTuberculosis VaccineTreatment Sale Price byType (2020-2025) & (USD/K Dose)
Table 10. GlobalTuberculosis VaccineTreatment Sale by Application (2020-2025) & (K Dose)
Table 11. GlobalTuberculosis VaccineTreatment Sale Market Share by Application (2020-2025)
Table 12. GlobalTuberculosis VaccineTreatment Revenue by Application (2020-2025) & ($ million)
Table 13. GlobalTuberculosis VaccineTreatment Revenue Market Share by Application (2020-2025)
Table 14. GlobalTuberculosis VaccineTreatment Sale Price by Application (2020-2025) & (USD/K Dose)
Table 15. GlobalTuberculosis VaccineTreatment Sales by Company (2020-2025) & (K Dose)
Table 16. GlobalTuberculosis VaccineTreatment Sales Market Share by Company (2020-2025)
Table 17. GlobalTuberculosis VaccineTreatment Revenue by Company (2020-2025) & ($ millions)
Table 18. GlobalTuberculosis VaccineTreatment Revenue Market Share by Company (2020-2025)
Table 19. GlobalTuberculosis VaccineTreatment Sale Price by Company (2020-2025) & (USD/K Dose)
Table 20. Key ManufacturersTuberculosis VaccineTreatment Producing Area Distribution and Sales Area
Table 21. PlayersTuberculosis VaccineTreatment Products Offered
Table 22.Tuberculosis VaccineTreatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. GlobalTuberculosis VaccineTreatment Sales by Geographic Region (2020-2025) & (K Dose)
Table 26. GlobalTuberculosis VaccineTreatment Sales Market Share Geographic Region (2020-2025)
Table 27. GlobalTuberculosis VaccineTreatment Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. GlobalTuberculosis VaccineTreatment Revenue Market Share by Geographic Region (2020-2025)
Table 29. GlobalTuberculosis VaccineTreatment Sales by Country/Region (2020-2025) & (K Dose)
Table 30. GlobalTuberculosis VaccineTreatment Sales Market Share by Country/Region (2020-2025)
Table 31. GlobalTuberculosis VaccineTreatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. GlobalTuberculosis VaccineTreatment Revenue Market Share by Country/Region (2020-2025)
Table 33. AmericasTuberculosis VaccineTreatment Sales by Country (2020-2025) & (K Dose)
Table 34. AmericasTuberculosis VaccineTreatment Sales Market Share by Country (2020-2025)
Table 35. AmericasTuberculosis VaccineTreatment Revenue by Country (2020-2025) & ($ millions)
Table 36. AmericasTuberculosis VaccineTreatment Sales byType (2020-2025) & (K Dose)
Table 37. AmericasTuberculosis VaccineTreatment Sales by Application (2020-2025) & (K Dose)
Table 38. APACTuberculosis VaccineTreatment Sales by Region (2020-2025) & (K Dose)
Table 39. APACTuberculosis VaccineTreatment Sales Market Share by Region (2020-2025)
Table 40. APACTuberculosis VaccineTreatment Revenue by Region (2020-2025) & ($ millions)
Table 41. APACTuberculosis VaccineTreatment Sales byType (2020-2025) & (K Dose)
Table 42. APACTuberculosis VaccineTreatment Sales by Application (2020-2025) & (K Dose)
Table 43. EuropeTuberculosis VaccineTreatment Sales by Country (2020-2025) & (K Dose)
Table 44. EuropeTuberculosis VaccineTreatment Revenue by Country (2020-2025) & ($ millions)
Table 45. EuropeTuberculosis VaccineTreatment Sales byType (2020-2025) & (K Dose)
Table 46. EuropeTuberculosis VaccineTreatment Sales by Application (2020-2025) & (K Dose)
Table 47. Middle East & AfricaTuberculosis VaccineTreatment Sales by Country (2020-2025) & (K Dose)
Table 48. Middle East & AfricaTuberculosis VaccineTreatment Revenue Market Share by Country (2020-2025)
Table 49. Middle East & AfricaTuberculosis VaccineTreatment Sales byType (2020-2025) & (K Dose)
Table 50. Middle East & AfricaTuberculosis VaccineTreatment Sales by Application (2020-2025) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities ofTuberculosis VaccineTreatment
Table 52. Key Market Challenges & Risks ofTuberculosis VaccineTreatment
Table 53. Key IndustryTrends ofTuberculosis VaccineTreatment
Table 54.Tuberculosis VaccineTreatment Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56.Tuberculosis VaccineTreatment Distributors List
Table 57.Tuberculosis VaccineTreatment Customer List
Table 58. GlobalTuberculosis VaccineTreatment SalesForecast by Region (2026-2031) & (K Dose)
Table 59. GlobalTuberculosis VaccineTreatment RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. AmericasTuberculosis VaccineTreatment SalesForecast by Country (2026-2031) & (K Dose)
Table 61. AmericasTuberculosis VaccineTreatment Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APACTuberculosis VaccineTreatment SalesForecast by Region (2026-2031) & (K Dose)
Table 63. APACTuberculosis VaccineTreatment Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. EuropeTuberculosis VaccineTreatment SalesForecast by Country (2026-2031) & (K Dose)
Table 65. EuropeTuberculosis VaccineTreatment RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & AfricaTuberculosis VaccineTreatment SalesForecast by Country (2026-2031) & (K Dose)
Table 67. Middle East & AfricaTuberculosis VaccineTreatment RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. GlobalTuberculosis VaccineTreatment SalesForecast byType (2026-2031) & (K Dose)
Table 69. GlobalTuberculosis VaccineTreatment RevenueForecast byType (2026-2031) & ($ millions)
Table 70. GlobalTuberculosis VaccineTreatment SalesForecast by Application (2026-2031) & (K Dose)
Table 71. GlobalTuberculosis VaccineTreatment RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 73. MerckTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 74. MerckTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Japan BCG Lab Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 78. Japan BCG LabTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 79. Japan BCG LabTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 80. Japan BCG Lab Main Business
Table 81. Japan BCG Lab Latest Developments
Table 82. Serum Institute of India Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 83. Serum Institute of IndiaTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 84. Serum Institute of IndiaTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 85. Serum Institute of India Main Business
Table 86. Serum Institute of India Latest Developments
Table 87. AJ Vaccines Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 88. AJ VaccinesTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 89. AJ VaccinesTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 90. AJ Vaccines Main Business
Table 91. AJ Vaccines Latest Developments
Table 92. BioFarma Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 93. BioFarmaTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 94. BioFarmaTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 95. BioFarma Main Business
Table 96. BioFarma Latest Developments
Table 97. GreenSignal Bio Pharma Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 98. GreenSignal Bio PharmaTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 99. GreenSignal Bio PharmaTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 100. GreenSignal Bio Pharma Main Business
Table 101. GreenSignal Bio Pharma Latest Developments
Table 102. China National Biotec Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 103. China National BiotecTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 104. China National BiotecTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 105. China National Biotec Main Business
Table 106. China National Biotec Latest Developments
Table 107. Biomed Lublin Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 108. Biomed LublinTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 109. Biomed LublinTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 110. Biomed Lublin Main Business
Table 111. Biomed Lublin Latest Developments
Table 112.Taj Pharmaceuticals Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 113.Taj PharmaceuticalsTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 114.Taj PharmaceuticalsTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 115.Taj Pharmaceuticals Main Business
Table 116.Taj Pharmaceuticals Latest Developments
Table 117. Ataulpho de Paiva Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 118. Ataulpho de PaivaTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 119. Ataulpho de PaivaTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 120. Ataulpho de Paiva Main Business
Table 121. Ataulpho de Paiva Latest Developments
Table 122. IVAC Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 123. IVACTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 124. IVACTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 125. IVAC Main Business
Table 126. IVAC Latest Developments
Table 127. Queen Saovabha Mem. Inst Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 128. Queen Saovabha Mem. InstTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 129. Queen Saovabha Mem. InstTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 130. Queen Saovabha Mem. Inst Main Business
Table 131. Queen Saovabha Mem. Inst Latest Developments
Table 132. Microgen Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 133. MicrogenTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 134. MicrogenTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 135. Microgen Main Business
Table 136. Microgen Latest Developments
LIST OFFIGURES
Figure 1. Picture ofTuberculosis VaccineTreatment
Figure 2.Tuberculosis VaccineTreatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTuberculosis VaccineTreatment Sales Growth Rate 2020-2031 (K Dose)
Figure 7. GlobalTuberculosis VaccineTreatment Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Tuberculosis VaccineTreatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Tuberculosis VaccineTreatment Sales Market Share by Country/Region (2024)
Figure 10.Tuberculosis VaccineTreatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immune Vaccine
Figure 12. Product Picture ofTherapy Vaccine
Figure 13. GlobalTuberculosis VaccineTreatment Sales Market Share byType in 2025
Figure 14. GlobalTuberculosis VaccineTreatment Revenue Market Share byType (2020-2025)
Figure 15.Tuberculosis VaccineTreatment Consumed in Self-Procurement
Figure 16. GlobalTuberculosis VaccineTreatment Market: Self-Procurement (2020-2025) & (K Dose)
Figure 17.Tuberculosis VaccineTreatment Consumed in UNICEF
Figure 18. GlobalTuberculosis VaccineTreatment Market: UNICEF (2020-2025) & (K Dose)
Figure 19.Tuberculosis VaccineTreatment Consumed in Other
Figure 20. GlobalTuberculosis VaccineTreatment Market: Other (2020-2025) & (K Dose)
Figure 21. GlobalTuberculosis VaccineTreatment Sale Market Share by Application (2024)
Figure 22. GlobalTuberculosis VaccineTreatment Revenue Market Share by Application in 2025
Figure 23.Tuberculosis VaccineTreatment Sales by Company in 2025 (K Dose)
Figure 24. GlobalTuberculosis VaccineTreatment Sales Market Share by Company in 2025
Figure 25.Tuberculosis VaccineTreatment Revenue by Company in 2025 ($ millions)
Figure 26. GlobalTuberculosis VaccineTreatment Revenue Market Share by Company in 2025
Figure 27. GlobalTuberculosis VaccineTreatment Sales Market Share by Geographic Region (2020-2025)
Figure 28. GlobalTuberculosis VaccineTreatment Revenue Market Share by Geographic Region in 2025
Figure 29. AmericasTuberculosis VaccineTreatment Sales 2020-2025 (K Dose)
Figure 30. AmericasTuberculosis VaccineTreatment Revenue 2020-2025 ($ millions)
Figure 31. APACTuberculosis VaccineTreatment Sales 2020-2025 (K Dose)
Figure 32. APACTuberculosis VaccineTreatment Revenue 2020-2025 ($ millions)
Figure 33. EuropeTuberculosis VaccineTreatment Sales 2020-2025 (K Dose)
Figure 34. EuropeTuberculosis VaccineTreatment Revenue 2020-2025 ($ millions)
Figure 35. Middle East & AfricaTuberculosis VaccineTreatment Sales 2020-2025 (K Dose)
Figure 36. Middle East & AfricaTuberculosis VaccineTreatment Revenue 2020-2025 ($ millions)
Figure 37. AmericasTuberculosis VaccineTreatment Sales Market Share by Country in 2025
Figure 38. AmericasTuberculosis VaccineTreatment Revenue Market Share by Country (2020-2025)
Figure 39. AmericasTuberculosis VaccineTreatment Sales Market Share byType (2020-2025)
Figure 40. AmericasTuberculosis VaccineTreatment Sales Market Share by Application (2020-2025)
Figure 41. United StatesTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 42. CanadaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 43. MexicoTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 44. BrazilTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 45. APACTuberculosis VaccineTreatment Sales Market Share by Region in 2025
Figure 46. APACTuberculosis VaccineTreatment Revenue Market Share by Region (2020-2025)
Figure 47. APACTuberculosis VaccineTreatment Sales Market Share byType (2020-2025)
Figure 48. APACTuberculosis VaccineTreatment Sales Market Share by Application (2020-2025)
Figure 49. ChinaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 50. JapanTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 51. South KoreaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast AsiaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 53. IndiaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 54. AustraliaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwanTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 56. EuropeTuberculosis VaccineTreatment Sales Market Share by Country in 2025
Figure 57. EuropeTuberculosis VaccineTreatment Revenue Market Share by Country (2020-2025)
Figure 58. EuropeTuberculosis VaccineTreatment Sales Market Share byType (2020-2025)
Figure 59. EuropeTuberculosis VaccineTreatment Sales Market Share by Application (2020-2025)
Figure 60. GermanyTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 61.FranceTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 62. UKTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 63. ItalyTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 64. RussiaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & AfricaTuberculosis VaccineTreatment Sales Market Share by Country (2020-2025)
Figure 66. Middle East & AfricaTuberculosis VaccineTreatment Sales Market Share byType (2020-2025)
Figure 67. Middle East & AfricaTuberculosis VaccineTreatment Sales Market Share by Application (2020-2025)
Figure 68. EgyptTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 69. South AfricaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 70. IsraelTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 71.TurkeyTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC CountriesTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis ofTuberculosis VaccineTreatment in 2025
Figure 74. Manufacturing Process Analysis ofTuberculosis VaccineTreatment
Figure 75. Industry Chain Structure ofTuberculosis VaccineTreatment
Figure 76. Channels of Distribution
Figure 77. GlobalTuberculosis VaccineTreatment Sales MarketForecast by Region (2026-2031)
Figure 78. GlobalTuberculosis VaccineTreatment Revenue Market ShareForecast by Region (2026-2031)
Figure 79. GlobalTuberculosis VaccineTreatment Sales Market ShareForecast byType (2026-2031)
Figure 80. GlobalTuberculosis VaccineTreatment Revenue Market ShareForecast byType (2026-2031)
Figure 81. GlobalTuberculosis VaccineTreatment Sales Market ShareForecast by Application (2026-2031)
Figure 82. GlobalTuberculosis VaccineTreatment Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tuberculosis Vaccine Treatment Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Tuberculosis Vaccine Treatment by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Tuberculosis Vaccine Treatment by Country/Region, 2020, 2024 & 2031
2.2 Tuberculosis Vaccine Treatment Segment by Type
2.2.1 Immune Vaccine
2.2.2 Therapy Vaccine
2.3 Tuberculosis Vaccine Treatment Sales by Type
2.3.1 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2020-2025)
2.3.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Type (2020-2025)
2.3.3 Global Tuberculosis Vaccine Treatment Sale Price by Type (2020-2025)
2.4 Tuberculosis Vaccine Treatment Segment by Application
2.4.1 Self-Procurement
2.4.2 UNICEF
2.4.3 Other
2.5 Tuberculosis Vaccine Treatment Sales by Application
2.5.1 Global Tuberculosis Vaccine Treatment Sale Market Share by Application (2020-2025)
2.5.2 Global Tuberculosis Vaccine Treatment Revenue and Market Share by Application (2020-2025)
2.5.3 Global Tuberculosis Vaccine Treatment Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Tuberculosis Vaccine Treatment Breakdown Data by Company
3.1.1 Global Tuberculosis Vaccine Treatment Annual Sales by Company (2020-2025)
3.1.2 Global Tuberculosis Vaccine Treatment Sales Market Share by Company (2020-2025)
3.2 Global Tuberculosis Vaccine Treatment Annual Revenue by Company (2020-2025)
3.2.1 Global Tuberculosis Vaccine Treatment Revenue by Company (2020-2025)
3.2.2 Global Tuberculosis Vaccine Treatment Revenue Market Share by Company (2020-2025)
3.3 Global Tuberculosis Vaccine Treatment Sale Price by Company
3.4 Key Manufacturers Tuberculosis Vaccine Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tuberculosis Vaccine Treatment Product Location Distribution
3.4.2 Players Tuberculosis Vaccine Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TUBERCULOSIS VACCINE TREATMENT BY GEOGRAPHIC REGION
4.1 World Historic Tuberculosis Vaccine Treatment Market Size by Geographic Region (2020-2025)
4.1.1 Global Tuberculosis Vaccine Treatment Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Tuberculosis Vaccine Treatment Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tuberculosis Vaccine Treatment Market Size by Country/Region (2020-2025)
4.2.1 Global Tuberculosis Vaccine Treatment Annual Sales by Country/Region (2020-2025)
4.2.2 Global Tuberculosis Vaccine Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tuberculosis Vaccine Treatment Sales Growth
4.4 APAC Tuberculosis Vaccine Treatment Sales Growth
4.5 Europe Tuberculosis Vaccine Treatment Sales Growth
4.6 Middle East & Africa Tuberculosis Vaccine Treatment Sales Growth
5 AMERICAS
5.1 Americas Tuberculosis Vaccine Treatment Sales by Country
5.1.1 Americas Tuberculosis Vaccine Treatment Sales by Country (2020-2025)
5.1.2 Americas Tuberculosis Vaccine Treatment Revenue by Country (2020-2025)
5.2 Americas Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
5.3 Americas Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis Vaccine Treatment Sales by Region
6.1.1 APAC Tuberculosis Vaccine Treatment Sales by Region (2020-2025)
6.1.2 APAC Tuberculosis Vaccine Treatment Revenue by Region (2020-2025)
6.2 APAC Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
6.3 APAC Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tuberculosis Vaccine Treatment by Country
7.1.1 Europe Tuberculosis Vaccine Treatment Sales by Country (2020-2025)
7.1.2 Europe Tuberculosis Vaccine Treatment Revenue by Country (2020-2025)
7.2 Europe Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
7.3 Europe Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tuberculosis Vaccine Treatment by Country
8.1.1 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Country (2020-2025)
8.1.2 Middle East & Africa Tuberculosis Vaccine Treatment Revenue by Country (2020-2025)
8.2 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Type (2020-2025)
8.3 Middle East & Africa Tuberculosis Vaccine Treatment Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccine Treatment
10.3 Manufacturing Process Analysis of Tuberculosis Vaccine Treatment
10.4 Industry Chain Structure of Tuberculosis Vaccine Treatment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tuberculosis Vaccine Treatment Distributors
11.3 Tuberculosis Vaccine Treatment Customer
12 WORLD FORECAST REVIEW FOR TUBERCULOSIS VACCINE TREATMENT BY GEOGRAPHIC REGION
12.1 Global Tuberculosis Vaccine Treatment Market Size Forecast by Region
12.1.1 Global Tuberculosis Vaccine Treatment Forecast by Region (2026-2031)
12.1.2 Global Tuberculosis Vaccine Treatment Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Tuberculosis Vaccine Treatment Forecast by Type (2026-2031)
12.7 Global Tuberculosis Vaccine Treatment Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.1.3 Merck Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Japan BCG Lab
13.2.1 Japan BCG Lab Company Information
13.2.2 Japan BCG Lab Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Japan BCG Lab Main Business Overview
13.2.5 Japan BCG Lab Latest Developments
13.3 Serum Institute of India
13.3.1 Serum Institute of India Company Information
13.3.2 Serum Institute of India Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Serum Institute of India Main Business Overview
13.3.5 Serum Institute of India Latest Developments
13.4 AJ Vaccines
13.4.1 AJ Vaccines Company Information
13.4.2 AJ Vaccines Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AJ Vaccines Main Business Overview
13.4.5 AJ Vaccines Latest Developments
13.5 BioFarma
13.5.1 BioFarma Company Information
13.5.2 BioFarma Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 BioFarma Main Business Overview
13.5.5 BioFarma Latest Developments
13.6 GreenSignal Bio Pharma
13.6.1 GreenSignal Bio Pharma Company Information
13.6.2 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 GreenSignal Bio Pharma Main Business Overview
13.6.5 GreenSignal Bio Pharma Latest Developments
13.7 China National Biotec
13.7.1 China National Biotec Company Information
13.7.2 China National Biotec Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 China National Biotec Main Business Overview
13.7.5 China National Biotec Latest Developments
13.8 Biomed Lublin
13.8.1 Biomed Lublin Company Information
13.8.2 Biomed Lublin Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biomed Lublin Main Business Overview
13.8.5 Biomed Lublin Latest Developments
13.9 Taj Pharmaceuticals
13.9.1 Taj Pharmaceuticals Company Information
13.9.2 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Taj Pharmaceuticals Main Business Overview
13.9.5 Taj Pharmaceuticals Latest Developments
13.10 Ataulpho de Paiva
13.10.1 Ataulpho de Paiva Company Information
13.10.2 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Ataulpho de Paiva Main Business Overview
13.10.5 Ataulpho de Paiva Latest Developments
13.11 IVAC
13.11.1 IVAC Company Information
13.11.2 IVAC Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.11.3 IVAC Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 IVAC Main Business Overview
13.11.5 IVAC Latest Developments
13.12 Queen Saovabha Mem. Inst
13.12.1 Queen Saovabha Mem. Inst Company Information
13.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Queen Saovabha Mem. Inst Main Business Overview
13.12.5 Queen Saovabha Mem. Inst Latest Developments
13.13 Microgen
13.13.1 Microgen Company Information
13.13.2 Microgen Tuberculosis Vaccine Treatment Product Portfolios and Specifications
13.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Microgen Main Business Overview
13.13.5 Microgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Tuberculosis VaccineTreatment Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Tuberculosis VaccineTreatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immune Vaccine
Table 4. Major Players ofTherapy Vaccine
Table 5. GlobalTuberculosis VaccineTreatment Sales byType (2020-2025) & (K Dose)
Table 6. GlobalTuberculosis VaccineTreatment Sales Market Share byType (2020-2025)
Table 7. GlobalTuberculosis VaccineTreatment Revenue byType (2020-2025) & ($ million)
Table 8. GlobalTuberculosis VaccineTreatment Revenue Market Share byType (2020-2025)
Table 9. GlobalTuberculosis VaccineTreatment Sale Price byType (2020-2025) & (USD/K Dose)
Table 10. GlobalTuberculosis VaccineTreatment Sale by Application (2020-2025) & (K Dose)
Table 11. GlobalTuberculosis VaccineTreatment Sale Market Share by Application (2020-2025)
Table 12. GlobalTuberculosis VaccineTreatment Revenue by Application (2020-2025) & ($ million)
Table 13. GlobalTuberculosis VaccineTreatment Revenue Market Share by Application (2020-2025)
Table 14. GlobalTuberculosis VaccineTreatment Sale Price by Application (2020-2025) & (USD/K Dose)
Table 15. GlobalTuberculosis VaccineTreatment Sales by Company (2020-2025) & (K Dose)
Table 16. GlobalTuberculosis VaccineTreatment Sales Market Share by Company (2020-2025)
Table 17. GlobalTuberculosis VaccineTreatment Revenue by Company (2020-2025) & ($ millions)
Table 18. GlobalTuberculosis VaccineTreatment Revenue Market Share by Company (2020-2025)
Table 19. GlobalTuberculosis VaccineTreatment Sale Price by Company (2020-2025) & (USD/K Dose)
Table 20. Key ManufacturersTuberculosis VaccineTreatment Producing Area Distribution and Sales Area
Table 21. PlayersTuberculosis VaccineTreatment Products Offered
Table 22.Tuberculosis VaccineTreatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. GlobalTuberculosis VaccineTreatment Sales by Geographic Region (2020-2025) & (K Dose)
Table 26. GlobalTuberculosis VaccineTreatment Sales Market Share Geographic Region (2020-2025)
Table 27. GlobalTuberculosis VaccineTreatment Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. GlobalTuberculosis VaccineTreatment Revenue Market Share by Geographic Region (2020-2025)
Table 29. GlobalTuberculosis VaccineTreatment Sales by Country/Region (2020-2025) & (K Dose)
Table 30. GlobalTuberculosis VaccineTreatment Sales Market Share by Country/Region (2020-2025)
Table 31. GlobalTuberculosis VaccineTreatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. GlobalTuberculosis VaccineTreatment Revenue Market Share by Country/Region (2020-2025)
Table 33. AmericasTuberculosis VaccineTreatment Sales by Country (2020-2025) & (K Dose)
Table 34. AmericasTuberculosis VaccineTreatment Sales Market Share by Country (2020-2025)
Table 35. AmericasTuberculosis VaccineTreatment Revenue by Country (2020-2025) & ($ millions)
Table 36. AmericasTuberculosis VaccineTreatment Sales byType (2020-2025) & (K Dose)
Table 37. AmericasTuberculosis VaccineTreatment Sales by Application (2020-2025) & (K Dose)
Table 38. APACTuberculosis VaccineTreatment Sales by Region (2020-2025) & (K Dose)
Table 39. APACTuberculosis VaccineTreatment Sales Market Share by Region (2020-2025)
Table 40. APACTuberculosis VaccineTreatment Revenue by Region (2020-2025) & ($ millions)
Table 41. APACTuberculosis VaccineTreatment Sales byType (2020-2025) & (K Dose)
Table 42. APACTuberculosis VaccineTreatment Sales by Application (2020-2025) & (K Dose)
Table 43. EuropeTuberculosis VaccineTreatment Sales by Country (2020-2025) & (K Dose)
Table 44. EuropeTuberculosis VaccineTreatment Revenue by Country (2020-2025) & ($ millions)
Table 45. EuropeTuberculosis VaccineTreatment Sales byType (2020-2025) & (K Dose)
Table 46. EuropeTuberculosis VaccineTreatment Sales by Application (2020-2025) & (K Dose)
Table 47. Middle East & AfricaTuberculosis VaccineTreatment Sales by Country (2020-2025) & (K Dose)
Table 48. Middle East & AfricaTuberculosis VaccineTreatment Revenue Market Share by Country (2020-2025)
Table 49. Middle East & AfricaTuberculosis VaccineTreatment Sales byType (2020-2025) & (K Dose)
Table 50. Middle East & AfricaTuberculosis VaccineTreatment Sales by Application (2020-2025) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities ofTuberculosis VaccineTreatment
Table 52. Key Market Challenges & Risks ofTuberculosis VaccineTreatment
Table 53. Key IndustryTrends ofTuberculosis VaccineTreatment
Table 54.Tuberculosis VaccineTreatment Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56.Tuberculosis VaccineTreatment Distributors List
Table 57.Tuberculosis VaccineTreatment Customer List
Table 58. GlobalTuberculosis VaccineTreatment SalesForecast by Region (2026-2031) & (K Dose)
Table 59. GlobalTuberculosis VaccineTreatment RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. AmericasTuberculosis VaccineTreatment SalesForecast by Country (2026-2031) & (K Dose)
Table 61. AmericasTuberculosis VaccineTreatment Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APACTuberculosis VaccineTreatment SalesForecast by Region (2026-2031) & (K Dose)
Table 63. APACTuberculosis VaccineTreatment Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. EuropeTuberculosis VaccineTreatment SalesForecast by Country (2026-2031) & (K Dose)
Table 65. EuropeTuberculosis VaccineTreatment RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & AfricaTuberculosis VaccineTreatment SalesForecast by Country (2026-2031) & (K Dose)
Table 67. Middle East & AfricaTuberculosis VaccineTreatment RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. GlobalTuberculosis VaccineTreatment SalesForecast byType (2026-2031) & (K Dose)
Table 69. GlobalTuberculosis VaccineTreatment RevenueForecast byType (2026-2031) & ($ millions)
Table 70. GlobalTuberculosis VaccineTreatment SalesForecast by Application (2026-2031) & (K Dose)
Table 71. GlobalTuberculosis VaccineTreatment RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 73. MerckTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 74. MerckTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. Japan BCG Lab Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 78. Japan BCG LabTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 79. Japan BCG LabTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 80. Japan BCG Lab Main Business
Table 81. Japan BCG Lab Latest Developments
Table 82. Serum Institute of India Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 83. Serum Institute of IndiaTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 84. Serum Institute of IndiaTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 85. Serum Institute of India Main Business
Table 86. Serum Institute of India Latest Developments
Table 87. AJ Vaccines Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 88. AJ VaccinesTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 89. AJ VaccinesTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 90. AJ Vaccines Main Business
Table 91. AJ Vaccines Latest Developments
Table 92. BioFarma Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 93. BioFarmaTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 94. BioFarmaTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 95. BioFarma Main Business
Table 96. BioFarma Latest Developments
Table 97. GreenSignal Bio Pharma Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 98. GreenSignal Bio PharmaTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 99. GreenSignal Bio PharmaTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 100. GreenSignal Bio Pharma Main Business
Table 101. GreenSignal Bio Pharma Latest Developments
Table 102. China National Biotec Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 103. China National BiotecTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 104. China National BiotecTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 105. China National Biotec Main Business
Table 106. China National Biotec Latest Developments
Table 107. Biomed Lublin Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 108. Biomed LublinTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 109. Biomed LublinTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 110. Biomed Lublin Main Business
Table 111. Biomed Lublin Latest Developments
Table 112.Taj Pharmaceuticals Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 113.Taj PharmaceuticalsTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 114.Taj PharmaceuticalsTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 115.Taj Pharmaceuticals Main Business
Table 116.Taj Pharmaceuticals Latest Developments
Table 117. Ataulpho de Paiva Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 118. Ataulpho de PaivaTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 119. Ataulpho de PaivaTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 120. Ataulpho de Paiva Main Business
Table 121. Ataulpho de Paiva Latest Developments
Table 122. IVAC Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 123. IVACTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 124. IVACTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 125. IVAC Main Business
Table 126. IVAC Latest Developments
Table 127. Queen Saovabha Mem. Inst Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 128. Queen Saovabha Mem. InstTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 129. Queen Saovabha Mem. InstTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 130. Queen Saovabha Mem. Inst Main Business
Table 131. Queen Saovabha Mem. Inst Latest Developments
Table 132. Microgen Basic Information,Tuberculosis VaccineTreatment Manufacturing Base, Sales Area and Its Competitors
Table 133. MicrogenTuberculosis VaccineTreatment Product Portfolios and Specifications
Table 134. MicrogenTuberculosis VaccineTreatment Sales (K Dose), Revenue ($ Million), Price (USD/K Dose) and Gross Margin (2020-2025)
Table 135. Microgen Main Business
Table 136. Microgen Latest Developments
LIST OFFIGURES
Figure 1. Picture ofTuberculosis VaccineTreatment
Figure 2.Tuberculosis VaccineTreatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTuberculosis VaccineTreatment Sales Growth Rate 2020-2031 (K Dose)
Figure 7. GlobalTuberculosis VaccineTreatment Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Tuberculosis VaccineTreatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Tuberculosis VaccineTreatment Sales Market Share by Country/Region (2024)
Figure 10.Tuberculosis VaccineTreatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immune Vaccine
Figure 12. Product Picture ofTherapy Vaccine
Figure 13. GlobalTuberculosis VaccineTreatment Sales Market Share byType in 2025
Figure 14. GlobalTuberculosis VaccineTreatment Revenue Market Share byType (2020-2025)
Figure 15.Tuberculosis VaccineTreatment Consumed in Self-Procurement
Figure 16. GlobalTuberculosis VaccineTreatment Market: Self-Procurement (2020-2025) & (K Dose)
Figure 17.Tuberculosis VaccineTreatment Consumed in UNICEF
Figure 18. GlobalTuberculosis VaccineTreatment Market: UNICEF (2020-2025) & (K Dose)
Figure 19.Tuberculosis VaccineTreatment Consumed in Other
Figure 20. GlobalTuberculosis VaccineTreatment Market: Other (2020-2025) & (K Dose)
Figure 21. GlobalTuberculosis VaccineTreatment Sale Market Share by Application (2024)
Figure 22. GlobalTuberculosis VaccineTreatment Revenue Market Share by Application in 2025
Figure 23.Tuberculosis VaccineTreatment Sales by Company in 2025 (K Dose)
Figure 24. GlobalTuberculosis VaccineTreatment Sales Market Share by Company in 2025
Figure 25.Tuberculosis VaccineTreatment Revenue by Company in 2025 ($ millions)
Figure 26. GlobalTuberculosis VaccineTreatment Revenue Market Share by Company in 2025
Figure 27. GlobalTuberculosis VaccineTreatment Sales Market Share by Geographic Region (2020-2025)
Figure 28. GlobalTuberculosis VaccineTreatment Revenue Market Share by Geographic Region in 2025
Figure 29. AmericasTuberculosis VaccineTreatment Sales 2020-2025 (K Dose)
Figure 30. AmericasTuberculosis VaccineTreatment Revenue 2020-2025 ($ millions)
Figure 31. APACTuberculosis VaccineTreatment Sales 2020-2025 (K Dose)
Figure 32. APACTuberculosis VaccineTreatment Revenue 2020-2025 ($ millions)
Figure 33. EuropeTuberculosis VaccineTreatment Sales 2020-2025 (K Dose)
Figure 34. EuropeTuberculosis VaccineTreatment Revenue 2020-2025 ($ millions)
Figure 35. Middle East & AfricaTuberculosis VaccineTreatment Sales 2020-2025 (K Dose)
Figure 36. Middle East & AfricaTuberculosis VaccineTreatment Revenue 2020-2025 ($ millions)
Figure 37. AmericasTuberculosis VaccineTreatment Sales Market Share by Country in 2025
Figure 38. AmericasTuberculosis VaccineTreatment Revenue Market Share by Country (2020-2025)
Figure 39. AmericasTuberculosis VaccineTreatment Sales Market Share byType (2020-2025)
Figure 40. AmericasTuberculosis VaccineTreatment Sales Market Share by Application (2020-2025)
Figure 41. United StatesTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 42. CanadaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 43. MexicoTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 44. BrazilTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 45. APACTuberculosis VaccineTreatment Sales Market Share by Region in 2025
Figure 46. APACTuberculosis VaccineTreatment Revenue Market Share by Region (2020-2025)
Figure 47. APACTuberculosis VaccineTreatment Sales Market Share byType (2020-2025)
Figure 48. APACTuberculosis VaccineTreatment Sales Market Share by Application (2020-2025)
Figure 49. ChinaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 50. JapanTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 51. South KoreaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast AsiaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 53. IndiaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 54. AustraliaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwanTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 56. EuropeTuberculosis VaccineTreatment Sales Market Share by Country in 2025
Figure 57. EuropeTuberculosis VaccineTreatment Revenue Market Share by Country (2020-2025)
Figure 58. EuropeTuberculosis VaccineTreatment Sales Market Share byType (2020-2025)
Figure 59. EuropeTuberculosis VaccineTreatment Sales Market Share by Application (2020-2025)
Figure 60. GermanyTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 61.FranceTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 62. UKTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 63. ItalyTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 64. RussiaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & AfricaTuberculosis VaccineTreatment Sales Market Share by Country (2020-2025)
Figure 66. Middle East & AfricaTuberculosis VaccineTreatment Sales Market Share byType (2020-2025)
Figure 67. Middle East & AfricaTuberculosis VaccineTreatment Sales Market Share by Application (2020-2025)
Figure 68. EgyptTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 69. South AfricaTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 70. IsraelTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 71.TurkeyTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC CountriesTuberculosis VaccineTreatment Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis ofTuberculosis VaccineTreatment in 2025
Figure 74. Manufacturing Process Analysis ofTuberculosis VaccineTreatment
Figure 75. Industry Chain Structure ofTuberculosis VaccineTreatment
Figure 76. Channels of Distribution
Figure 77. GlobalTuberculosis VaccineTreatment Sales MarketForecast by Region (2026-2031)
Figure 78. GlobalTuberculosis VaccineTreatment Revenue Market ShareForecast by Region (2026-2031)
Figure 79. GlobalTuberculosis VaccineTreatment Sales Market ShareForecast byType (2026-2031)
Figure 80. GlobalTuberculosis VaccineTreatment Revenue Market ShareForecast byType (2026-2031)
Figure 81. GlobalTuberculosis VaccineTreatment Sales Market ShareForecast by Application (2026-2031)
Figure 82. GlobalTuberculosis VaccineTreatment Revenue Market ShareForecast by Application (2026-2031)
